India’s first fully indigenously developed Pneumococcal Polysaccharide Conjugate Vaccine (Pneumonia vaccine) has received the approval from Drug Controller General of India (DCGI). It will be utilized for active immunization against invasive disease and pneumonia caused by “Streptococcus pneumonia” among infants.
Pneumococcal Polysaccharide Conjugate Vaccine (Pneumonia vaccine) has been developed by Serum Institute of India Pvt Ltd, Pune. It is India’s first indigenously developed vaccine in the field of pneumonia. With the DCGI’s approval, Serum Institute of India has been granted permission to manufacture the vaccine domestically.
As travelers seek inspiration for their next adventure, the world offers a plethora of stunning…
Himachal Pradesh, nestled in the lap of the majestic Himalayas, is a paradise for nature…
The Defence Research and Development Organisation (DRDO) has achieved a significant milestone in enhancing India's…
Zimbabwe has launched a new currency called the ZiG (short for Zimbabwe Gold) in an…
The Uttarakhand government has suspended the manufacturing licenses of 14 products from Patanjali Ayurved, founded…
The Reserve Bank of India (RBI) has revoked the license of Acemoney (India) Limited, a…